Building a Biotech: Company Creation 101

Are you interested in what it takes to build a biotech company from the ground up? If so, apply to attend our upcoming program, Building a Biotech: Company Creation 101, taking place September 25th at JLABS SSF.

This half-day educational program is tailored for early-stage life science innovators and entrepreneurs focused on areas of strategic interest to Johnson & Johnson. It aims to provide insights into the complexities of launching a biotech venture. From translating academic discoveries into startups to navigating funding, IP, and early-stage decision-making, this program is built to equip you with practical knowledge and inspiration.

The event will feature three dynamic sessions, including:

• A featured presentation titled “VC 101” by Lior Teitelbaum of JJDC, focused on venture capital fundamentals and early investment insights
• A panel discussion, “Navigating the Path for Biotech Entrepreneurship: Insights from Investors and Founders,” featuring leaders who have built and backed successful biotech startups. Panelists include Lior Teitelbaum, Principal of Venture Investments, JJDC, David Allison, Managing Director, Westlake BioPartners, K. Angela MacFarlane, CEO, Perceive Biotherapeutics, and Darren Cooke, Interim Chief Innovation & Entrepreneurship Officer, UC Berkeley
• A focused session on legal and IP protection led by Georgina Jones Suzuki of Ropes & Gray, covering foundational legal concepts for new ventures

Following the program, attendees will be invited to connect with speakers and peers during a networking lunch.

Whether you’re a scientist with a breakthrough discovery or a business-minded individual looking to bring new solutions to patients, this is an excellent opportunity to gain the strategic guidance you need to succeed in the biotech startup ecosystem.